Comparative Toxicity of Nanomaterials In Vitro and In Vivo
Public Domain
-
2005/03/13
-
Details
-
Personal Author:Arepalli S ; Baron, Paul A. ; Castranova, Vincent ; Gorelik O ; Hubbs A ; Johnson VJ ; Kagan VE ; Kisin E ; Maynard AD ; Mercer RR ; Murray AR ; Potapovich AI ; Shvedova AA
-
Description:Society is currently amidst with revolutionary developments of remarkable new technologies based on novel applications of nanomaterials. A comparative in vitro study of nanosized particles revealed dose-dependent formation of granulomatous bronochointerstitial pneumonia, fibrosis, and changed pulmonary function in C57BL/6 mice. Administration of CNT to mice also resulted in a dose-dependent augmentation of biomarkers of inflammation quantified by lavage cell counts, total protein, lactate dehydrogenase and glutamyltranspeptidase activities in BAL fluids and accumulation of pro-inflammatory and pro-fibrotic cytokines. Overall, our data suggest that in vivo exposure to CNT leads to pulmonary toxicity realized through the synergized interactions of inflammatory response and oxidative stress culminating in the development of multifocal granulomatous pneumonia and fibrosis. The value of both approaches will be discussed in line with assessment of adverse outcomes of nanomaterials. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0065-7727
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:229
-
NIOSHTIC Number:nn:20027576
-
Citation:Abstr Pap - Am Chem Soc 2005 Mar; 229(Pt 1):014-IEC
-
Federal Fiscal Year:2005
-
NORA Priority Area:
-
Peer Reviewed:False
-
Part Number:1
-
Source Full Name:Abstracts of papers - American Chemical Society
-
Collection(s):
-
Main Document Checksum:urn:sha-512:0f7d39e3a925ba8adf73377afcabe9a03f38cc851a8bde5628a9b771f65d8c7b42c3a491ff88ee63161cdba06fb35e0bf210ee2fd36763fd9df63d8ce6ccc52c
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like